NYSE:XTNT

Xtant Medical Holdings Stock News

etoro logo Buy XTNT
*Your capital is at risk
$0.460
-0.0049 (-1.05%)
At Close: Jun 03, 2026
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q4 2021 Results - Earnings Call Transcript
BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2021, before the open of the financial markets on Tuesday, March 8, 2022.
BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di
New York, USA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Global Orthobiologics Market is Anticipated to Grow at a CAGR of 4.44% During the Forecast Period (2021-26) | DelveInsight As per DelveInsight analysis, a growing geriatric population at risk of developing various bone degenerative disorders, an increase in traumatic injuries such as car accidents, sports injuries, and others are expected to boost the Orthobiologics market growth. Furthermore rising investments in R&D and collaborations by key manufacturers, as well as an increase in various orthobiologic product approvals will also drive the market. DelveInsight''s Orthobiologics Market Insights and Forecast report provides the current and forecast Orthobiologics market, upcoming developments in the medical devices, individual market shares, challenges, drivers, barriers, market growth trends, and key players in the Orthobiologics market. Some of the Key Highlights from the Orthobiologics Market Report According to DelveInsight analysis, North America is expected to dominate the overall Orthobiologics Market during the forecasted period.

Xtant Medical (XTNT) Investor Presentation - Slideshow

11:49pm, Friday, 21'st Jan 2022 Seeking Alpha
Xtant Medical Holdings Inc. (XTNT) shares closed 4.0% lower than its previous 52 week low, giving the company a market cap of $52M. The stock is currently down 49.0% year-to-date, down 50.0% over the past 12 months, and down 91.4% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 73.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 183.5% The company's stock price performance over the past 12 months lags the peer average by 166.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Xtant Medical Holdings Inc. (XTNT) shares closed 3.1% lower than its previous 52 week low, giving the company a market cap of $57M. The stock is currently down 44.8% year-to-date, down 44.8% over the past 12 months, and down 90.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 105.4% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 199.9% The company's stock price performance over the past 12 months lags the peer average by 180.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Xtant Medical Holdings Inc. (XTNT) shares closed today at 1.5% above its 52 week low of $0.65, giving the company a market cap of $61M. The stock is currently down 40.2% year-to-date, down 37.8% over the past 12 months, and down 89.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 20.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 165.2% The company's stock price performance over the past 12 months lags the peer average by 122.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
BIMI International Medical Inc. (BIMI) with the stream of -9.20% also noticed, India Xtant Medical Holdings, Inc. (XTNT) encountered a rapid change of -4.53% in the last hour of trading The post Alarming Stock: BIMI International Medical Inc. (NASDAQ:BIMI), Xtant Medical Holdings, Inc. (AMEX:XTNT) appeared first on Stocks Equity .

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Update

03:36pm, Sunday, 05'th Dec 2021 Dakota Financial News
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 197,600 shares, a decrease of 21.7% from the October 31st total of 252,500 shares. Based on an average daily volume of 140,900 shares, the days-to-cover ratio []
Xtant Medical Holdings Inc. (XTNT) shares closed 2.8% lower than its previous 52 week low, giving the company a market cap of $64M. The stock is currently down 38.1% year-to-date, down 40.3% over the past 12 months, and down 87.5% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.6%. Trading Activity Trading volume this week was 6.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 271.4% The company's stock price performance over the past 12 months lags the peer average by 102.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Xtant Medical Holdings' (XTNT) CEO Sean Browne on Q3 2021 Results - Earnings Call Transcript
BELGRADE, Mont., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q2 2021 Results - Earnings Call Transcript
BELGRADE, Mont., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE